Medicine Mondiale

• Home
• About Us
• Our Projects
• Our Partners
• Blog
• Contact Us

Our Projects

Medicine Mondiale develops and distributes medicines and medical technology through a network of global social entrepreneurs and partners. We assist local partners in the establishment of sustainable healthcare initiatives which make quality healthcare outcomes accessible to the poorest of the poor.

Cataract Surgery

The Problem
In 1992 the average cost for an Intraocular Lens required for modern cataract surgery was US$300. The lack of availability of affordable lenses was a major impediment to the adoption of modern cataract surgery throughout the developing world. Millions of people were unnecessarily blind due to the high costs and availability of Intraocular Lenses.

The Solution

Between 1993 and 1997 Ray Avery CEO and Founder of Medicine Mondiale designed and commissioned two state of the art Intraocular lens (IOL) laboratories one in Eritrea and one in Nepal.

Today these laboratories supply 10% of the world market for IOL's and together with the efforts of other generic lens manufacturers have seen the price of lenses decrease to less than $6.00 making modern cataract surgery available to the poorest of the poor.

To purchase high quality Intraocular lenses contact:

fhlab@eol.com
sales@tilganga.com.np

Infant Nutrition

The Problem

Acute diarrhoea is the leading cause of death in infants under two years of age while protein energy malnutrition accounts for over half of all child deaths in developing countries. Diarrhoeal infections and malnutrition disrupt the patient’s ability to digest and absorb protein. Breaking down large proteins and carbohydrates requires energy and patients may die of protein malnutrition or organ failure even with a full stomach of food because they lack the necessary enzymes for digestion.

The Solution

Medicine Mondiale is developing an improved range of nutritional products for the treatment of dehydration and protein energy malnutrition which may be used in combination to combat acute diarrhoea and protein energy malnutrition on a global scale. These novel products are based upon pre-digested protein formulations which provide an instant source of energy through the rapid absorption of amino acids.

Pilot scale production validation is underway and commercial production will commence in 2008.

Acuset Improved IV Flow Controller

The Problem

The traditional "roller clamp" used to administer Intravenous fluids and medicines is not intuitive to use and due to it's highly sensitive adjustment mechanism, medical staff have difficulty in maintaining accurate infusion rates. In the developing world, particularly in crisis situations, patients are often left to treat themselves. The under administration of medicines such as antibiotics results in increased rates of patient morbidity while over administration of potent hypnotic and chemotherapy drugs may result in death.

The Solution

The Medicine Mondiale Acuset TM flow controller is intuitive to use even by relatively untrained operators.

The Acuset's Patented dial-a -flow mechanism allows flow rates to be set with a high degree of accuracy and precision improving patient safety and making every dollar spent on healthcare stretch further.

The Medicine Mondiale Acuset Intravenous Flow controller has the potential to save millions of lives and improve the quality of clinical care in almost every clinical discipline throughout the developing world.

Learn more about Acuset

Infant Incubator

The Problem
Worldwide every year five million infants die as a result of low birth weight and infection. The majority of these deaths could be prevented if infants had access to high tech life saving incubators. Sadly these, first world incubators cost over $15,000 and cannot be serviced and maintained locally.

The Solution

Commercial production is expected to commence in June 2008.

Cancer Treatment Nepal 

The Problem
Less that 0.2% of women in Nepal are routinely screened for life threatening invasive cancers. Thousands more Nepalese cannot afford treatment for curable cancers and many poor patients die without access to palliative care.

The Solution